サンバイオの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2025/04/17 | 2,140 | 2,280 | 2,112 | 2,255 | +115 | +5.4% | 7,568,200 |
| 2025/04/16 | 2,180 | 2,185 | 2,079 | 2,140 | ±0 | ±0% | 4,740,100 |
| 2025/04/15 | 2,096 | 2,153 | 2,046 | 2,140 | +140 | +7% | 8,206,100 |
| 2025/04/14 | 1,847 | 2,086 | 1,815 | 2,000 | +195 | +10.8% | 8,612,800 |
| 2025/04/11 | 1,620 | 1,805 | 1,620 | 1,805 | +131 | +7.8% | 4,388,700 |
| 2025/04/10 | 1,713 | 1,717 | 1,614 | 1,674 | +128 | +8.3% | 3,007,000 |
| 2025/04/09 | 1,626 | 1,669 | 1,481 | 1,546 | -107 | -6.5% | 3,255,100 |
| 2025/04/08 | 1,579 | 1,653 | 1,563 | 1,653 | +265 | +19.1% | 2,844,300 |
| 2025/04/07 | 1,520 | 1,555 | 1,388 | 1,388 | -239 | -14.7% | 4,027,700 |
| 2025/04/04 | 1,680 | 1,766 | 1,583 | 1,627 | -51 | -3% | 4,774,300 |
| 2025/04/03 | 1,550 | 1,708 | 1,550 | 1,678 | +41 | +2.5% | 3,142,100 |
| 2025/04/02 | 1,644 | 1,659 | 1,567 | 1,637 | -30 | -1.8% | 3,256,600 |
| 2025/04/01 | 1,800 | 1,850 | 1,633 | 1,667 | +20 | +1.2% | 11,704,500 |
| 2025/03/31 | 1,602 | 1,695 | 1,567 | 1,647 | -8 | -0.5% | 3,407,600 |
| 2025/03/28 | 1,623 | 1,781 | 1,622 | 1,655 | +10 | +0.6% | 7,918,000 |
| 2025/03/27 | 1,630 | 1,686 | 1,620 | 1,645 | -21 | -1.3% | 6,672,400 |
| 2025/03/26 | 1,440 | 1,675 | 1,412 | 1,666 | +256 | +18.2% | 10,909,700 |
| 2025/03/25 | 1,335 | 1,416 | 1,312 | 1,410 | +89 | +6.7% | 2,886,200 |
| 2025/03/24 | 1,359 | 1,396 | 1,308 | 1,321 | -39 | -2.9% | 2,787,100 |
| 2025/03/21 | 1,347 | 1,445 | 1,307 | 1,360 | +59 | +4.5% | 4,706,400 |
| 2025/03/19 | 1,278 | 1,416 | 1,269 | 1,301 | +4 | +0.3% | 6,402,400 |
| 2025/03/18 | 1,134 | 1,299 | 1,115 | 1,297 | +133 | +11.4% | 4,695,800 |
| 2025/03/17 | 1,149 | 1,180 | 1,133 | 1,164 | +11 | +1% | 1,498,000 |
| 2025/03/14 | 1,114 | 1,167 | 1,095 | 1,153 | +37 | +3.3% | 1,584,000 |
| 2025/03/13 | 1,119 | 1,142 | 1,100 | 1,116 | +12 | +1.1% | 895,600 |
| 2025/03/12 | 1,088 | 1,130 | 1,079 | 1,104 | +14 | +1.3% | 854,900 |
| 2025/03/11 | 1,086 | 1,093 | 1,053 | 1,090 | -22 | -2% | 996,800 |
| 2025/03/10 | 1,101 | 1,117 | 1,063 | 1,112 | +9 | +0.8% | 996,000 |
| 2025/03/07 | 1,075 | 1,112 | 1,066 | 1,103 | +10 | +0.9% | 816,000 |
| 2025/03/06 | 1,157 | 1,165 | 1,091 | 1,093 | -40 | -3.5% | 1,437,000 |
| 2025/03/05 | 1,133 | 1,166 | 1,113 | 1,133 | -4 | -0.4% | 1,148,100 |
| 2025/03/04 | 1,168 | 1,168 | 1,111 | 1,137 | -32 | -2.7% | 1,255,900 |
| 2025/03/03 | 1,131 | 1,180 | 1,124 | 1,169 | +48 | +4.3% | 1,438,800 |
| 2025/02/28 | 1,156 | 1,198 | 1,114 | 1,121 | -49 | -4.2% | 1,886,100 |
| 2025/02/27 | 1,210 | 1,215 | 1,164 | 1,170 | -22 | -1.8% | 1,866,700 |
| 2025/02/26 | 1,115 | 1,202 | 1,083 | 1,192 | +73 | +6.5% | 2,721,800 |
| 2025/02/25 | 1,127 | 1,161 | 1,102 | 1,119 | -31 | -2.7% | 1,483,300 |
| 2025/02/21 | 1,105 | 1,183 | 1,081 | 1,150 | +35 | +3.1% | 2,407,700 |
| 2025/02/20 | 1,108 | 1,135 | 1,087 | 1,115 | -9 | -0.8% | 1,351,200 |
| 2025/02/19 | 1,133 | 1,208 | 1,113 | 1,124 | +9 | +0.8% | 3,961,800 |
| 2025/02/18 | 1,050 | 1,132 | 1,050 | 1,115 | +60 | +5.7% | 2,165,100 |
| 2025/02/17 | 1,019 | 1,122 | 1,018 | 1,055 | +24 | +2.3% | 3,175,400 |
| 2025/02/14 | 1,028 | 1,065 | 995 | 1,031 | +10 | +1% | 2,438,900 |
| 2025/02/13 | 1,069 | 1,069 | 1,008 | 1,021 | -4 | -0.4% | 3,140,300 |
| 2025/02/12 | 1,270 | 1,300 | 1,019 | 1,025 | -84 | -7.6% | 10,840,400 |
| 2025/02/10 | 1,109 | 1,109 | 1,109 | 1,109 | +150 | +15.6% | 80,300 |
| 2025/02/07 | 959 | 959 | 959 | 959 | +150 | +18.5% | 88,500 |
| 2025/02/06 | 759 | 818 | 757 | 809 | +42 | +5.5% | 923,200 |
| 2025/02/05 | 742 | 806 | 742 | 767 | +25 | +3.4% | 1,394,400 |
| 2025/02/04 | 754 | 754 | 718 | 742 | -6 | -0.8% | 439,800 |
51～
100
件表示中 / 2500件
類似銘柄と比較する
現在ご覧いただいている「サンバイオ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| サンバイオ | 233,200円 | - | - | 0.00% | - | 111.58倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
| キッセイ薬 | 401,000円 | +3.6% | +6.1% | 2.99% | 13.51倍 | 0.80倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
| 鳥居薬 | 632,000円 | +7.1% | -35.0% | 0.00% | 52.26倍 | 1.46倍 |
|
ＪＴ傘下。皮膚疾患や腎・透析、花粉症薬などアレルゲン領域に強み。塩野義製薬がＴＯＢ実施 |
| 科研薬 | 379,100円 | -6.4% | -71.8% | 5.01% | 42.34倍 | 0.95倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| ジーエヌアイ | 330,000円 | +21.7% | +999.9% | 0.00% | 13.83倍 | 4.76倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
市場注目の銘柄
チャート関連のコラム
